Fig. 1From: Time and productivity loss associated with immunotherapy infusions for the treatment of melanoma in the United States: a survey of health care professionals and patientsMean, minimum, and maximum time (in minutes) oncologists spend per patient and infusion visit by immunotherapy regimen administered. P-values assess if differences by immunotherapy regimen are significantBack to article page